Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients—the PRIMO study.Cardiovasc Drugs Ther. 2005; 19: 403-414
- An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents.J Altern Complement Med. 2001; 7: 133-139
- Constituents of red yeast rice, a traditional Chinese food and medicine.J Agric Food Chem. 2000; 48: 5220-5225
- Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis.Am J Med. 2000; 109: 72-73
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).JAMA. 2001; 285: 2486-2497
- Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement.Am J Clin Nutr. 1999; 69: 231-236
- Efficacy and safety of Monascus purpureus went rice in subjects with hyperlipidemia.Eur J Endocrinol. 2005; 153: 679-686
- Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials.Chin Med. 2006; 1: 4
- Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial.Mayo Clin Proc. 2008; 83: 758-764
- Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.Ann Intern Med. 2009; 150: 830-839
- Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients.Eur J Cardiovasc Prev Rehabil. 2007; 14: 438-440
- A “natural” threat.Am J Med. 2007; 120: e3-e4
- Symptomatic myopathy due to red yeast rice.Ann Intern Med. 2006; 145: 474-475
- Chinese red rice-induced myopathy.South Med J. 2003; 96: 1265-1267
- Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment.J Am Geriatr Soc. 2006; 54: 718-720
- Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient.Transplantation. 2002; 74: 1200-1201
- Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian surveillance system of natural health products.Br J Clin Pharmacol. 2008; 66: 572-574
- Symptomatic hepatitis associated with the use of herbal red yeast rice.Ann Intern Med. 2008; 149: 516-517
Dr. Wortham is on the Speaker's Bureau of Novartis (East Hanover, New Jersey), Sanofi Aventis (Bridgewater, New Jersey); Dr. Thompson has received grant/research support from Merck (West Point, Pennsylvania), Pfizer (New York, New York), Astra Zeneca (Wilmington, Delaware), B. Braun (Bethlehem, Pennsylvania), GlaxoSmithKline (Research Triangle Pk, North Carolina), Roche (Nutley, New Jersey), and Genomas (Hartford, Connecticut); has been a Consultant to Astra Zeneca, Merck, Schering-Plough (Liberty Corner, New Jersey), Takeda (Deerfield, Illinois), Roche, Genomas, and Abbott (North Chicago, Illinois); has been on the Speaker's Bureau for Merck, Pfizer, Abbott, Astra Zeneca, Schering-Plough, Stock; and has been a shareholder in Zoll (Chelmsford, Massachusetts), General Electric (Fairfield, Connecticut), JA Wiley Publishing (StreetHoboken, New Jersey), Zimmer (West Center Street Warsaw, Indiana), Medtronic (Minneapolis, Minnesota), and Merck. Work performed at the Cholesterol Management Center, Henry Low Heart Center, Hartford Hospital, Hartford, Connecticut.